Method for treating neurodegenerative diseases
AssigneeThe Board of Trustees of the Leland Stanford Junio R University
InventorsKhoa Dinh NGUYEN, Edgar G. ENGLEMAN
Life of this patent
Estimating the term…
Abstract
The present invention is directed to a method for treating a neurodegenerative disease such as amyotrophic lateral sclerosis (ALS), Alzheimer disease, Parkinson's disease, Huntington's disease, frontotemporal degeneration, dementia with Lewy bodies, a motor neuron disease, or a demyelinating disease. The method comprises administering to a subject in need thereof a Ppargc1a activator 2-(4-tert-butylphenyl)-1H-benzimidazole, 2-[4-(1,1-dimethylethyl)phenyl]-1H-benzimidazole, in an effective amount. A preferred route of administration is oral administration.
Claims12
A method of treating a neurodegenerative disease, comprising the step of administering to a subject suffering from a neurodegenerative disease an effective amount of 2-(4-tert-butylphenyl)-1H-benzimidazole.
Dependencies are inferred from the claim text.